Lisata Therapeutics, Inc. (LSTA)

Lisata Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	28	22	20	50	28	26
Market Cap Growth	-0.14%	11.75%	-60.48%	81.39%	6.25%	-25.50%
Enterprise Value	-15	-32	-55	-50	-12	-2
Last Close Price	3.12	2.73	2.53	12.62	21.45	37.65
PE Ratio	-	-1.06	-0.24	-1.70	-2.71	-1.34
PB Ratio	0.65	0.46	0.30	0.55	0.86	1.27
P/FCF Ratio	-1.37	-1.11	-0.93	-2.26	-3.14	-1.38
P/OCF Ratio	-1.37	-1.11	-0.94	-2.26	-3.14	-1.38
EV/EBITDA Ratio	0.97	1.26	2.04	1.72	0.63	0.11
EV/EBIT Ratio	0.96	1.25	2.03	1.71	0.63	0.11
EV/FCF Ratio	1.30	1.60	2.58	2.23	1.37	0.12
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.02	0.05
Debt / FCF Ratio	-0.01	-0.02	-0.02	-0.03	-0.07	-0.05
Quick Ratio	8.13	7.82	10.96	21.00	9.86	4.21
Current Ratio	8.92	8.18	11.26	21.27	10.08	4.35
Return on Equity (ROE)	-38.77%	-36.49%	-68.50%	-44.21%	-30.84%	-66.72%
Return on Assets (ROA)	-27.78%	-25.16%	-20.00%	-27.30%	-37.89%	-35.01%
Return on Capital (ROIC)	-30.57%	-27.94%	-21.32%	-28.92%	-43.99%	-42.58%
Earnings Yield	-71.31%	-93.79%	-272.69%	-54.59%	-29.38%	-74.17%
FCF Yield	-67.08%	-90.15%	-107.90%	-44.33%	-31.88%	-72.33%
Buyback Yield / Dilution	-3.84%	-55.85%	-40.46%	-258.29%	-49.54%	-6.56%
Total Shareholder Return	-3.84%	-55.85%	-40.46%	-258.29%	-49.54%	-6.56%

Source: S&P Capital IQ. Standard template.